Tenon Medical AAQS
The The AAQS of Tenon Medical (TNON) as of Oct 21, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).
Get this data via API
Financial Data API
AAQS
3
YoY
0.00%
Last updated:
Tenon Medical has a current AAQS of 3.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Tenon Medical in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Tenon Medical in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
The Tenon Medical AAQS history
3 Years
10 Years
25 Years
Max
AAQS
Date
AAQS
Jan 1, 2019
3.00 USD
Jan 1, 2020
3.00 USD
Jan 1, 2021
3.00 USD
Jan 1, 2022
3.00 USD
Jan 1, 2023
3.00 USD
Jan 1, 2024
3.00 USD
Jan 1, 2025
3.00 USD
| YEAR | AAQS | YoY |
|---|---|---|
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | 0.00% | |
| 3 | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Tenon Medical Stock analysis
What does Tenon Medical do? Tenon Medical Inc generates revenue through the sale of its Catamaran SI Joint Fusion System, a medical device designed to treat sacroiliac joint disorders causing lower back pain. The system includes the Catamaran Fixation Device, which stabilizes the SI Joint by transfixing it along its longitudinal axis using a single titanium implant. The company targets orthopedic surgeons and hospitals specializing in spinal and joint treatments, with the Catamaran System marketed as a solution for the most common SI Joint disorders. Tenon Technology AG serves as the company's subsidiary, supporting the development and commercialization of the medical device technology.
The Catamaran System is positioned as a specialized surgical solution, featuring a unique approach that avoids critical neural and vascular structures while targeting strong cortical bone. The company's focus on the sacroiliac joint market differentiates it from broader orthopedic device manufacturers, with the product designed to address specific patient needs in lower back pain management. Revenue streams are derived from direct sales of the system to healthcare providers and hospitals, leveraging the proprietary surgical technique and implant design.
Tenon Medical Inc. operates within the Health Care Equipment & Supplies industry, with its primary product being the Catamaran SI Joint Fusion System. The company's business model centers on developing and selling medical devices that provide targeted treatment for SI Joint disorders, using a single titanium implant that transfixes the joint. The subsidiary Tenon Technology AG plays a role in supporting the company's technological advancements and market positioning. Tenon Medical is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Tenon Medical stock
The AAQS of Tenon Medical is 3 in 2025.
On Eulerpool you can find the complete historical development of The AAQS Tenon Medical since 2006 – with annual values, charts, and detailed analysis.
The AAQS is a key figure developed by AlleAktien.
The AAQS is a key figure developed by AlleAktien.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quality — Tenon Medical
All Key Metrics — Tenon Medical
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth